These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 39329452)

  • 21. ZNF703 promotes triple-negative breast cancer cells through cell-cycle signaling and associated with poor prognosis.
    Zhang X; Mu X; Huang O; Wang Z; Chen J; Chen D; Wang G
    BMC Cancer; 2022 Mar; 22(1):226. PubMed ID: 35236318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. POLD2 is activated by E2F1 to promote triple-negative breast cancer proliferation.
    Zhang Z
    Front Oncol; 2022; 12():981329. PubMed ID: 36119494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive analysis and establishment of a prediction model of alternative splicing events reveal the prognostic predictor and immune microenvironment signatures in triple negative breast cancer.
    Yu S; Hu C; Liu L; Cai L; Du X; Yu Q; Lin F; Zhao J; Zhao Y; Zhang C; Liu X; Li W
    J Transl Med; 2020 Jul; 18(1):286. PubMed ID: 32723333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RNA
    Tan B; Zhou K; Liu W; Prince E; Qing Y; Li Y; Han L; Qin X; Su R; Pokharel SP; Yang L; Zhao Z; Shen C; Li W; Chen Z; Zhang Z; Deng X; Small A; Wang K; Leung K; Chen CW; Shen B; Chen J
    Theranostics; 2022; 12(13):5727-5743. PubMed ID: 35966596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
    Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L
    Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. E2F1 transcriptionally regulates CCNA2 expression to promote triple negative breast cancer tumorigenicity.
    Lu Y; Su F; Yang H; Xiao Y; Zhang X; Su H; Zhang T; Bai Y; Ling X
    Cancer Biomark; 2022; 33(1):57-70. PubMed ID: 34366326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PCMT1 knockdown attenuates malignant properties by globally regulating transcriptome profiles in triple-negative breast cancer cells.
    Saiding A; Maimaitiyiming D; Chen M; Yan F; Chen D; Hu X; Shi P
    PeerJ; 2023; 11():e16006. PubMed ID: 37953789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PDSS1-Mediated Activation of CAMK2A-STAT3 Signaling Promotes Metastasis in Triple-Negative Breast Cancer.
    Yu TJ; Liu YY; Li XG; Lian B; Lu XX; Jin X; Shao ZM; Hu X; Di GH; Jiang YZ
    Cancer Res; 2021 Nov; 81(21):5491-5505. PubMed ID: 34408002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kynurenine 3-monooxygenase upregulates pluripotent genes through β-catenin and promotes triple-negative breast cancer progression.
    Huang TT; Tseng LM; Chen JL; Chu PY; Lee CH; Huang CT; Wang WL; Lau KY; Tseng MF; Chang YY; Chiang TY; Ueng YF; Lee HC; Dai MS; Liu CY
    EBioMedicine; 2020 Apr; 54():102717. PubMed ID: 32268268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ESM1 promotes triple-negative breast cancer cell proliferation through activating AKT/NF-κB/Cyclin D1 pathway.
    Liu W; Yang Y; He B; Ma F; Sun F; Guo M; Zhang M; Dong Z
    Ann Transl Med; 2021 Apr; 9(7):533. PubMed ID: 33987231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional Interaction Between the Oncogenic Kinase NEK2 and Sam68 Promotes a Splicing Program Involved in Migration and Invasion in Triple-Negative Breast Cancer.
    Naro C; Barbagallo F; Caggiano C; De Musso M; Panzeri V; Di Agostino S; Paronetto MP; Sette C
    Front Oncol; 2022; 12():880654. PubMed ID: 35530315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deubiquitylase YOD1 regulates CDK1 stability and drives triple-negative breast cancer tumorigenesis.
    Han Z; Jia Q; Zhang J; Chen M; Wang L; Tong K; He W; Zhang Y; Zhu W; Qin J; Wang T; Liu T; Ma Y; Chen Y; Zha S; Zhang C
    J Exp Clin Cancer Res; 2023 Sep; 42(1):228. PubMed ID: 37667382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CENPF knockdown inhibits adriamycin chemoresistance in triple-negative breast cancer via the Rb-E2F1 axis.
    Wang D; Xu W; Huang M; Ma W; Liu Y; Zhou X; Yang Q; Mu K
    Sci Rep; 2023 Jan; 13(1):1803. PubMed ID: 36720923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of TDP43 inhibits progression of triple-negative breast cancer in coordination with SRSF3.
    Ke H; Zhao L; Zhang H; Feng X; Xu H; Hao J; Wang S; Yang Q; Zou L; Su X; Wang L; Wu C; Wang Y; Nie J; Jiao B
    Proc Natl Acad Sci U S A; 2018 Apr; 115(15):E3426-E3435. PubMed ID: 29581274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GAPVD1 Promotes the Proliferation of Triple-Negative Breast Cancer Cells by Regulating the ERK/MAPK Signaling Pathway.
    Wang L; Zhang L; Luo P; Xia Z; Shao S; Ning Q; Gu S; Zhao X; Luo M
    Curr Cancer Drug Targets; 2024 Jul; ():. PubMed ID: 39021189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TRA2A Promoted Paclitaxel Resistance and Tumor Progression in Triple-Negative Breast Cancers via Regulating Alternative Splicing.
    Liu T; Sun H; Zhu D; Dong X; Liu F; Liang X; Chen C; Shao B; Wang M; Wang Y; Sun B
    Mol Cancer Ther; 2017 Jul; 16(7):1377-1388. PubMed ID: 28416606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated expression of the rhythm gene NFIL3 promotes the progression of TNBC by activating NF-κB signaling through suppression of NFKBIA transcription.
    Yang W; Li J; Zhang M; Yu H; Zhuang Y; Zhao L; Ren L; Gong J; Bi H; Zeng L; Xue Y; Yang J; Zhao Y; Wang S; Gao S; Fu Z; Li D; Zhang J; Wang T; Shan M; Tang B; Li X
    J Exp Clin Cancer Res; 2022 Feb; 41(1):67. PubMed ID: 35180863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. H3K27ac-induced RHOXF2 activates Wnt2/β-catenin pathway by binding to HOXC13 to aggravate the malignant progression of triple negative breast cancer.
    Guo M; Wang R; Nie M; Zhang H; Wang C; Song C; Niu S
    Cell Signal; 2024 Aug; 120():111196. PubMed ID: 38697448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulator of G protein signaling 20 correlates with clinicopathological features and prognosis in triple-negative breast cancer.
    Li Q; Jin W; Cai Y; Yang F; Chen E; Ye D; Wang Q; Guan X
    Biochem Biophys Res Commun; 2017 Apr; 485(3):693-697. PubMed ID: 28237701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis.
    Wang R; Huang Z; Qian C; Wang M; Zheng Y; Jiang R; Yu C
    Biochem Biophys Res Commun; 2020 Jun; 526(4):1005-1012. PubMed ID: 32307083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.